CLINICAL_TRIALS
trial_result
· 2016-07-19
Clinical Trial Update: LIME Study (LFB IVIg MMN Efficacy Study) [Phase 3]
Summary
Phase 3 study assessing intravenous immunoglobulin (IVIg) for multifocal motor neuropathy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Laboratoire français de Fractionnement et de Biotechnologies | Conditions: Motor Neuron Disease | Phase 3 | Status: COMPLETED